Who We Are

Who We Are 2017-10-30T10:51:23-04:00
Cabernet Pharmaceuticals


At Cabernet Pharmaceuticals we are committed to helping our clients develop precise medicines by exploiting genetic insights into disease and response to pharmaceutical therapy. Bringing this pharmacogenetics (PGx) approach to drug development responds to a demand for greater therapeutic precision from every constituency of Cabernet clients—regulators, payers, physicians, and patients—while also offering the potential to improve R&D pipeline efficiency and shorten drug-development times. Our consultants have long been industry leaders in applying PGx to maximize R&D resources, working side-by-side with Cabernet clients not only to conceive PGx strategies but also to execute clinical studies, prepare regulatory submissions, and develop plans for post-marketing pharmacovigilance.